ArmaVir Partners

NJOY, Inc. is an American company based in Scottsdale, Arizona, that specializes in the manufacture and distribution of electronic cigarettes and vaping products aimed at adult smokers. Founded in 2006, NJOY offers a range of products, including rechargeable and non-rechargeable electronic cigarette kits, disposable electronic cigarettes, and various accessories such as chargers and batteries. The company positions itself as a pioneer in the vaping industry, providing innovative alternatives to traditional combustible cigarettes. NJOY markets its products both online and through a comprehensive network of retail outlets, convenience stores, and dealers across all 50 states in the United States. With a commitment to serving the growing vaping market, NJOY continues to be a recognized leader in the sector.

Calder Group is a manufacturer specializing in engineered components for various critical industries. Their product range includes precision-engineered components, lead and bronze engineered products, and nuclear shielding, containment, and remote handling equipment. The company serves markets such as aerospace and defense, marine, nuclear, oil and gas, construction, healthcare, security, and others, providing reliable mission-critical products tailored to each sector's specific needs.

NJOY, Inc. is an American company based in Scottsdale, Arizona, that specializes in the manufacture and distribution of electronic cigarettes and vaping products aimed at adult smokers. Founded in 2006, NJOY offers a range of products, including rechargeable and non-rechargeable electronic cigarette kits, disposable electronic cigarettes, and various accessories such as chargers and batteries. The company positions itself as a pioneer in the vaping industry, providing innovative alternatives to traditional combustible cigarettes. NJOY markets its products both online and through a comprehensive network of retail outlets, convenience stores, and dealers across all 50 states in the United States. With a commitment to serving the growing vaping market, NJOY continues to be a recognized leader in the sector.

PAX Labs, Inc. is a prominent manufacturer of loose-leaf vaporizers and accessories designed for dry herbs and concentrates. With a focus on innovation and premium design, PAX offers a range of products including the PAX 3, PAX 2, and PAX Era, alongside their related accessories. The company also provides an online mobile application to enhance user experience. Founded in 2004 and initially known as Ploom, Inc., PAX Labs rebranded in 2015 and has since established itself as a leader in the vaporization technology sector. Headquartered in San Francisco, California, PAX Labs distributes its products through a network of retailers and distributors in the United States and internationally, as well as via online platforms.

NJOY, Inc. is an American company based in Scottsdale, Arizona, that specializes in the manufacture and distribution of electronic cigarettes and vaping products aimed at adult smokers. Founded in 2006, NJOY offers a range of products, including rechargeable and non-rechargeable electronic cigarette kits, disposable electronic cigarettes, and various accessories such as chargers and batteries. The company positions itself as a pioneer in the vaping industry, providing innovative alternatives to traditional combustible cigarettes. NJOY markets its products both online and through a comprehensive network of retail outlets, convenience stores, and dealers across all 50 states in the United States. With a commitment to serving the growing vaping market, NJOY continues to be a recognized leader in the sector.

Bluebird bio, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on researching, developing, and commercializing gene therapies for severe genetic diseases and cancer. The company's gene therapy programs include LentiGlobin, aimed at treating β-thalassemia and sickle cell disease, and Lenti-D for cerebral adrenoleukodystrophy. In oncology, bluebird bio is developing chimeric antigen receptor T (CAR T) cell therapies, specifically bb2121 and bb21217, for multiple myeloma. The company has formed strategic collaborations with several organizations, including Bristol-Myers Squibb and Regeneron Pharmaceuticals, to advance gene therapies in oncology and immune cell therapies. Additionally, bluebird bio collaborates with various partners to explore T cell receptor product candidates and in vivo genome editing treatments for genetic disorders. Established in 1992 and originally known as Genetix Pharmaceuticals, the company transitioned to its current name in 2010.

Cascadian Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Seattle, Washington, focused on developing innovative therapeutic products for cancer treatment. The company's lead product candidate, tucatinib, is an oral, HER2-selective small molecule tyrosine kinase inhibitor currently undergoing two Phase Ib clinical trials for metastatic breast cancer in combination therapies. In addition to tucatinib, Cascadian Therapeutics is advancing its preclinical pipeline, which includes CASC-578, a Chk1 cell cycle inhibitor, and CASC-674, an antibody targeting immuno-oncology. The company has established collaborative agreements with Array BioPharma for tucatinib development, Sentinel Oncology for novel Chk1 inhibitors, and Adimab for discovering new antibodies targeting immunotherapy in oncology. Founded in 1985 and formerly known as Oncothyreon Inc., Cascadian Therapeutics continues to focus on providing targeted therapies that aim to improve cancer treatment outcomes.

Biomoda, Inc. is an in-vitro diagnostics company focused on developing assays for cancer detection, particularly early-stage lung cancer. Founded in 1990 and headquartered in Albuquerque, New Mexico, Biomoda is advancing its proprietary CyPath assay, which utilizes a patented porphyrin application to identify cancerous cells in deep-lung sputum samples. The company is also expanding its research to create diagnostic solutions for various other cancers, including breast, oral, prostate, bladder, colorectal, and cervical cancers. Biomoda collaborates with the New Mexico Institute of Mining and Technology for clinical studies aimed at early lung cancer detection among veterans. Additionally, it has partnered with Medical Acoustics to incorporate their Lung Flute device into its collection protocol. The company is supported in navigating the FDA approval process through contracts with Quintiles Consulting and Alquest, Inc.

SinoHub, Inc. is an electronics company based in Shenzhen, China, that operates globally in two main segments: Integrated Contract Manufacturing (ICM) and Electronic Component Sales and Services (ECSS). The ICM segment specializes in the production of custom, private label mobile phones and tablets, primarily targeting customers in developing countries. Meanwhile, the ECSS segment focuses on the sales of electronic components and offers comprehensive supply chain management services, including procurement, warehousing, logistics, and import/export facilitation for manufacturers and design houses. Additionally, SinoHub provides a proprietary web-based software platform that streamlines the management of electronic component purchases and movement, enhancing efficiency in inventory and order tracking. Founded in 2000, SinoHub serves a diverse clientele that includes contract manufacturers, original equipment manufacturers (OEMs), and electronics manufacturing services (EMS) companies.

CEL-SCI Corporation is a biotechnology company headquartered in Vienna, Virginia, specializing in the research and development of immunotherapy products aimed at treating cancer and infectious diseases. The company's lead investigational product, Multikine, is undergoing a phase III clinical trial for the treatment of head and neck cancer. Additionally, CEL-SCI is advancing its Ligand Epitope Antigen Presentation System (LEAPS), a patented pre-clinical technology designed to stimulate the human immune system to combat various infections and medical conditions, including autoimmune diseases and allergies. The company is also working on multiple product candidates such as LEAPS-H1N1-DC for infectious diseases, and CEL-2000 and CEL-4000 for rheumatoid arthritis. Furthermore, CEL-SCI is developing LEAPS COV-19, an immunotherapy candidate targeting COVID-19, in collaboration with the University of Georgia’s Center for Vaccines and Immunology. Founded in 1983, CEL-SCI continues to leverage its expertise in drug discovery and development to address significant health challenges.

BravoSolution SpA specializes in supply management technology software and services aimed at enhancing procurement and sourcing processes. The company provides a range of solutions, including Spend Analysis to optimize savings and compliance, eSourcing for collaborative sourcing efforts, and supplier performance management tools. Its Contract Management service streamlines contract processes to ensure users realize savings from their negotiations. Notable products include BravoAlign, a cloud-based procurement alignment solution, and BravoAdvantage, a comprehensive platform that supports procurement initiatives from demand to contract. Additionally, BravoAdvantage Analytics offers data visualization tools, enabling procurement professionals to create intuitive reports and dashboards. BravoSolution also delivers collaboration services and government solutions related to spend visibility and electronic sourcing. Founded in 2000 and headquartered in Milan, Italy, BravoSolution operates offices in multiple countries, including the United States, Brazil, and several European nations. As of late 2017, it functions as a subsidiary of JAGGAER, Inc.

EarlyBirdCapital, Inc. is a registered broker-dealer and boutique investment banking firm located in New York City, established in 2000. The firm specializes in providing investment banking services to smaller capitalization companies and focuses on equity offerings, private placements, public offerings, mergers and acquisitions, debt placements, and valuation services. EarlyBirdCapital has developed significant expertise in Special Purpose Acquisition Companies (SPACs), serving as an underwriter for SPAC initial public offerings. The firm is a member of several regulatory bodies, including the Financial Industry Regulatory Authority and the Municipal Securities Rulemaking Board, ensuring compliance and oversight in its operations.

ci4net.com is a European economic network, or "Econet". The Company currently owns 50% or more of 26 Internet companies involved in Business-to-Business, Business-to-Consumer, e-Commerce and infrastructure. ci4net.com is focused on adding value at all stages of a company's development via its network. ci4net.com can provide infrastructure technologies, operational and management resources and synergistic access to a network of portfolio companies.

Xceed has been creating top-of-the-line software components for nearly 20 years. Their current product line boasts over 135 professional components, which are used by more than 100,000 professional developers worldwide, including Microsoft in applications such as Visual Studio 2010 and 2012 and Microsoft Office. Their focus is on creating and marketing UI controls that help developers and designers create a compelling user experience (UX) with the Windows Presentation Foundation (WPF), the backbone of LOB solutions. Xceed DataGrid for WPF is their flagship product. Their extensive offering also includes some of the most popular UI controls and data manipulation libraries for .NET (such as Zip and FTP), as well as controls and libraries for Silverlight, Windows Phone, and ActiveX/COM.